How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:56
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move that will help widen insurance
2023-07-07 08:53
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
2023-07-07 03:26
Alphabet Exuberance Is Cooling on Wall Street After Stock’s Strong Run
Once one of the highest-rated stocks on Wall Street, Alphabet Inc. is getting a cooler reception from analysts
2023-07-06 21:48
Teva Weighs Sale of $2 Billion Active Ingredients Unit
Teva Pharmaceutical Industries Ltd. is weighing options for its active ingredients business, including a possible sale, people with
2023-07-06 15:50
Moderna Signs Deal to Make mRNA Vaccines for Chinese Market
Moderna Inc. will push toward producing messenger RNA vaccines for China, seeking a foothold in the world’s second-largest
2023-07-05 18:46
OBS Group Nearing Deal for Bayer Pharma Assets in Pakistan, Sources Say
Pakistan’s OBS Group is nearing a deal to acquire pharmaceutical assets in the country from Bayer AG, according
2023-07-05 17:24
China Takes the Trade Fight to Europe, Targeting the Green Transition
China’s decision to restrict critical mineral exports will hit critical sectors in the European Union’s effort to decarbonize
2023-07-04 11:19
New AstraZeneca Cancer Drug Shows Potential in Key Study
An AstraZeneca Plc cancer medicine showed a statistically significant improvement over standard chemotherapy in a high-level study. The
2023-07-03 14:47
Bolsonaro to Be Banned From Public Office in Brazil for Eight Years
Brazil’s electoral court voted to ban Jair Bolsonaro from office for eight years for making false claims about
2023-07-01 07:45
Biotech Cyteir’s Drug Flop Turns Into Boon for Investors on Cash Return
A little-known biotech company, Cyteir Therapeutics Inc., notched its best day ever — on the back of plans
2023-07-01 04:58
Novartis Sells Eye Drugs to Bausch for Up to $2.5 Billion
Novartis AG agreed to sell part of its portfolio of eye medicines to Bausch + Lomb Corp. in
2023-06-30 20:47